3 completed. 2 Phase 4, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow N.M. Wulffraat: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease Human papilloma virus vaccine (cervarix) - Juvenile Idiopathic Arthritis, Systemic Lupus Erythematosus | Phase 4 | Completed | N.M. Wulffraat | 135 | 2009-02-01 | 2017-11-13 |
| Treatment of Steroid Resistant GVHD by Infusion MSC MSC (hPPL) - Graft-versus-host-disease | Phase 1 / Phase 2 | Completed | N.M. Wulffraat | 50 | 2009-01-01 | 2014-11-06 |
| Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis Measles, Mumps, Rubella vaccination - Arthritis, Juvenile Rheumatoid | Phase 4 | Completed | N.M. Wulffraat | 140 | 2008-05-01 | 2014-07-30 |
Arthritis, Juvenile (2) · Dermatomyositis (1) · Graft vs Host Disease (1) · Lupus Erythematosus, Systemic (1)
Papillomavirus Vaccines (1) · halofantrine (1) · human papillomavirus vaccine, L1 type 16, 18 (1)
Netherlands (3)
Fiona van der KLis, MD, PhD (1) · Guy Berbers, PhD (1) · Jurgen H Kuball, MD (1) · Nico M Wulffraat (1) · Nico M Wulffraat, MD, PhD (1) · Nico M. Wulffraat, MD;PhD (1)